Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Walid Saliba, MD, is Director of the Electrophysiology Lab, Associate Section Head of the Pacing and Electrophysiology Section, Co-Director of the Ventricular Arrhythmia Center, Medical Director of the Center for Atrial Fibrillation, and a Staff Cardiologist in the Section of Cardiac Electrophysiology and Pacing in the Robert and Suzanne Tomsich Department of Cardiovascular Medicine at Cleveland Clinic. He is board-certified in cardiac electrophysiology, cardiovascular disease and internal medicine. Dr. Saliba is trained in all aspects of clinical cardiac electrophysiology and pacing, including catheter ablation of various arrhythmias, implantation of cardiac pacemakers and defibrillators and extraction of implanted pacemaker and ICD leads using laser technology.
A native of Lebanon, Dr. Saliba did his undergraduate work at the American University of Beirut, graduating with Distinction and a degree in physics. He continued at the American University where he made the Dean’s Honor List during his medical studies and earned his medical degree. He is fluent in English, French and Arabic. He moved to the United States where he completed an internship and residency program in internal medicine at Duke University Medical Center in Durham, N.C., before receiving a fellowship in cardiology from Baylor College of Medicine in Houston, Texas.
Prior to joining Cleveland Clinic in 1998, Dr. Saliba was Medical Director of the Cardiac Rehabilitation Center and Medical Director of the Cardiopulmonary Laboratory of Jones Memorial Hospital in Wellsville, N.Y., where he worked as a Staff Cardiologist. Cleveland Clinic awarded him a fellowship in the subspecialty of cardiac electrophysiology, and he was appointed to Cleveland Clinic as a Staff Cardiologist and Cardiac Electrophysiologist in 1999.
Dr. Saliba’s research has focused on topics related to new treatments for atrial fibrillation, and pacemaker and defibrillator performance. He has been an invited lecturer at many national meetings and symposia, presenting on topics related to new therapies and ablation of atrial fibrillation, pacemaker implant techniques including biventricular systems, arresting arrhythmia and sudden cardiac death. He has authored or co-authored articles in leading scientific journals such as Circulation, Journal of the American College of Cardiology, the American Journal of Cardiology, Cardiovascular Electrophysiology Review and the Journal of Cardiovascular Electrophysiology.
Dr. Saliba is a member of the Heart Rhythm Society and the American College of Cardiology.
Abnormal Heart Rhythms, Long QT Syndrome, Atrial Fibrillation, Supraventricular Tachycardia, Ventricular Tachycardia, Biventricular Pacemaker, Catheter Ablation, Lead Extraction, Implantable Cardioverter Defibrillator, Pacemaker Implant, Pulmonary Vein Isolation Ablation
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 6/29/2015, Dr. Saliba has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.